ABPI

News

UK is becoming an 'outlier' for pharma, hitting investment

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

Market Access

blue and white medication capsule tablets

NHS medicines spending in England in greater focus

Leela Barham provides a perspective on the ABPI blog that covers understanding NHS medicines spending in England.

News

Novo Nordisk returns to ABPI fold after two-year suspension

Novo Nordisk has reached the end of its two-year suspension from the ABPI for breaches of its code of practice after making "sustained improvements."

News

Pharma furious as UK Statutory Scheme rebate rate soars

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.

News

Lawrence Tallon will lead MHRA after June Raine retires

Lawrence Tallon has been named head of the MHRA, effective 1st April, replacing Dame June Raine who is retiring.

News

Pharma urges NHS to put medicines at heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

UK is becoming an 'outlier' for pharma, hitting investment

NHS medicines spending in England in greater focus

Novo Nordisk returns to ABPI fold after two-year suspension

Pharma furious as UK Statutory Scheme rebate rate soars

Lawrence Tallon will lead MHRA after June Raine retires

Pharma urges NHS to put medicines at heart of 10-year plan

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

ABPI

Editor's Picks